Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacopeia To Trade Under Accelrys Symbol on Nasdaq

NEW YORK, Feb. 27 (GenomeWeb News) - Pharmacopeia will begin trading on the Nasdaq today under the ticker symbol "ACCL," the company said yesterday. The change comes as Pharmacopeia prepares to take on the name "Accelrys" as part of a planned reorganization that includes the spin-off of its drug discovery unit.

 

The company announced its spin-off plan in December. Pharmacopeia's drug discovery unit will become a separate company with the name Pharmacopeia Drug Discovery, while the original company will continue to operate the Accerlys software business under the Accelrys name. The company said yesterday that it will request approval of the name change at its upcoming 2004 stockholder meeting. Meanwhile, PPD has applied for a listing on the Nasdaq National Market under the ticker symbol "PCOP."

 

The spin-off is expected to formally take place by the end of the present quarter, Pharmacopeia said.

 

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.